Skip to Main content Skip to Navigation
Journal articles

Accelerated Caco-2 cell permeability model for drug discovery

Abstract : Introduction: By culturing Caco-2 cells according to a new and optimized protocol, it has been possible to accelerate the cell culture process in such a way that the cells can be used for experiments after only 6 days. The accelerated Caco-2 model has been compared to the traditional model (requiring 21-25 days of culture) in terms of tightness of the junctions, ability to rank chemical compounds for apparent permeability, active efflux and to discriminate P-gp substrates. Methods and results: In the new protocol, Caco-2 cells were cultured with the classical Caco-2 medium supplemented with puromycin. The initial cell seeding density was increased two times compared to the traditional procedure and the presence of a low concentration of puromycin in the culture medium reduced the Caco-2 permeability of mannitol. Bi-directional studies were performed with known P-gp substrates (rhodamine 123, digoxin and saquinavir) and with a total of 20 marketed drugs covering a wide range of physicochemical characteristics and therapeutic indications. Strong correlations were obtained between the apparent permeability in absorptive (Papp A→B) or secretory (Papp B→A) of the drugs in the accelerated model and in the traditional models and comparable efflux ratios were observed in the two studied models. Discussion: The new protocol reduces costs for screening and leads to higher throughput compared to traditional Caco-2 cell models. This accelerated model provides short time-feedback to the drug design during the early stage of drug discovery.
Document type :
Journal articles
Complete list of metadata
Contributor : Virginie Justin-Labonne <>
Submitted on : Monday, March 23, 2020 - 2:42:37 PM
Last modification on : Thursday, May 20, 2021 - 3:08:04 PM




Emmanuel Sevin, L. Dehouck, A. Fabulas-da Costa, R. Cecchelli, M.P. Dehouck, et al.. Accelerated Caco-2 cell permeability model for drug discovery. Journal of Pharmacological and Toxicological Methods, Elsevier, 2013, 68 (3), pp.334-339. ⟨10.1016/j.vascn.2013.07.004⟩. ⟨hal-02515314⟩



Record views